-
1
-
-
14244272868
-
PHENIX: Building new software for automated crystallographic structure determination
-
Adams, P. D., R. W. Grosse-Kunstleve, L. W. Hung, T. R. Ioerger, A. J. McCoy, N. W. Moriarty, R. J. Read, J. C. Sacchettini, N. K. Sauter, and T. C. Terwilliger. 2002. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58: 1948-1954.
-
(2002)
Acta Crystallogr. D Biol. Crystallogr
, vol.58
, pp. 1948-1954
-
-
Adams, P.D.1
Grosse-Kunstleve, R.W.2
Hung, L.W.3
Ioerger, T.R.4
McCoy, A.J.5
Moriarty, N.W.6
Read, R.J.7
Sacchettini, J.C.8
Sauter, N.K.9
Terwilliger, T.C.10
-
2
-
-
34247625945
-
Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold
-
Aleshin, A. E., S. A. Shiryaev, A. Y. Strongin, and R. C. Liddington. 2007. Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold. Protein Sci. 16:795-806.
-
(2007)
Protein Sci
, vol.16
, pp. 795-806
-
-
Aleshin, A.E.1
Shiryaev, S.A.2
Strongin, A.Y.3
Liddington, R.C.4
-
3
-
-
0028103275
-
The CCP4 suite: Programs for protein crystallography
-
Collaborative Computational Project Number 4
-
Collaborative Computational Project Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50:760-763.
-
(1994)
Acta Crystallogr. D Biol. Crystallogr
, vol.50
, pp. 760-763
-
-
-
4
-
-
36749073433
-
The design of drugs for HIV and HCV
-
De Clercq, E. 2007. The design of drugs for HIV and HCV. Nat. Rev. Drug Discov. 6:1001-1018.
-
(2007)
Nat. Rev. Drug Discov
, vol.6
, pp. 1001-1018
-
-
De Clercq, E.1
-
5
-
-
65549122954
-
-
Ekonomiuk, D., X. C. Su, K. Ozawa, C. Bodenreider, S. P. Lim, Z. Yin, T. H. Keller, D. Beer, V. Patel, G. Otting, A. Caflisch, and D. Huang. 2009. Discovery of a non-peptidic inhibitor of West Nile virus NS3 protease by high-throughput docking. PLoS Negl. Trop. Dis. 3:e356.
-
Ekonomiuk, D., X. C. Su, K. Ozawa, C. Bodenreider, S. P. Lim, Z. Yin, T. H. Keller, D. Beer, V. Patel, G. Otting, A. Caflisch, and D. Huang. 2009. Discovery of a non-peptidic inhibitor of West Nile virus NS3 protease by high-throughput docking. PLoS Negl. Trop. Dis. 3:e356.
-
-
-
-
7
-
-
33745025763
-
Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus
-
Erbel, P., N. Schiering, A. D'Arcy, M. Renatus, M. Kroemer, S. P. Lim, Z. Yin, T. H. Keller, S. G. Vasudevan, and U. Hommel. 2006. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat. Struct. Mol. Biol. 13:372-373.
-
(2006)
Nat. Struct. Mol. Biol
, vol.13
, pp. 372-373
-
-
Erbel, P.1
Schiering, N.2
D'Arcy, A.3
Renatus, M.4
Kroemer, M.5
Lim, S.P.6
Yin, Z.7
Keller, T.H.8
Vasudevan, S.G.9
Hommel, U.10
-
8
-
-
33748929006
-
Thermofluor-based high-throughput stability optimization of proteins for structural studies
-
Ericsson, U. B., B. M. Hallberg, G. T. Detitta, N. Dekker, and P. Nordlund. 2006. Thermofluor-based high-throughput stability optimization of proteins for structural studies. Anal. Biochem. 357:289-298.
-
(2006)
Anal. Biochem
, vol.357
, pp. 289-298
-
-
Ericsson, U.B.1
Hallberg, B.M.2
Detitta, G.T.3
Dekker, N.4
Nordlund, P.5
-
9
-
-
0025864149
-
Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins
-
Falgout, B., M. Pethel, Y. M. Zhang, and C. J. Lai. 1991. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J. Virol. 65:2467-2475.
-
(1991)
J. Virol
, vol.65
, pp. 2467-2475
-
-
Falgout, B.1
Pethel, M.2
Zhang, Y.M.3
Lai, C.J.4
-
10
-
-
38049053633
-
HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus
-
Johnston, P. A., J. Phillips, T. Y. Shun, S. Shinde, J. S. Lazo, D. M. Huryn, M. C. Myers, B. I. Ratnikov, J. W. Smith, Y. Su, R. Dahl, N. D. Cosford, S. A. Shiryaev, and A. Y. Strongin. 2007. HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus. Assay Drug Dev. Technol. 5:737-750.
-
(2007)
Assay Drug Dev. Technol
, vol.5
, pp. 737-750
-
-
Johnston, P.A.1
Phillips, J.2
Shun, T.Y.3
Shinde, S.4
Lazo, J.S.5
Huryn, D.M.6
Myers, M.C.7
Ratnikov, B.I.8
Smith, J.W.9
Su, Y.10
Dahl, R.11
Cosford, N.D.12
Shiryaev, S.A.13
Strongin, A.Y.14
-
11
-
-
0036004555
-
In vitro determination of dengue virus type 2 NS2B-NS3 protease activity with fluorescent peptide substrates
-
Khumthong, R., C. Angsuthanasombat, S. Panyim, and G. Katzenmeier. 2002. In vitro determination of dengue virus type 2 NS2B-NS3 protease activity with fluorescent peptide substrates. J. Biochem. Mol. Biol. 35:206-212.
-
(2002)
J. Biochem. Mol. Biol
, vol.35
, pp. 206-212
-
-
Khumthong, R.1
Angsuthanasombat, C.2
Panyim, S.3
Katzenmeier, G.4
-
12
-
-
16044364658
-
Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide
-
Kim, J. L., K. A. Morgenstern, C. Lin, T. Fox, M. D. Dwyer, J. A. Landro, S. P. Chambers, W. Markland, C. A. Lepre, E. T. O'Malley, S. L. Harbeson, C. M. Rice, M. A. Murcko, P. R. Caron, and J. A. Thomson. 1996. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87:343-355.
-
(1996)
Cell
, vol.87
, pp. 343-355
-
-
Kim, J.L.1
Morgenstern, K.A.2
Lin, C.3
Fox, T.4
Dwyer, M.D.5
Landro, J.A.6
Chambers, S.P.7
Markland, W.8
Lepre, C.A.9
O'Malley, E.T.10
Harbeson, S.L.11
Rice, C.M.12
Murcko, M.A.13
Caron, P.R.14
Thomson, J.A.15
-
13
-
-
53249121029
-
Towards the design of antiviral inhibitors against flaviviruses: The case for the multifunctional NS3 protein from dengue virus as a target
-
Lescar, J., D. Luo, T. Xu, A. Sampath, S. P. Lim, B. Canard, and S. G. Vasudevan. 2008. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from dengue virus as a target. Antiviral Res. 80:94-101.
-
(2008)
Antiviral Res
, vol.80
, pp. 94-101
-
-
Lescar, J.1
Luo, D.2
Xu, T.3
Sampath, A.4
Lim, S.P.5
Canard, B.6
Vasudevan, S.G.7
-
14
-
-
0035824539
-
Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors
-
Leung, D., K. Schroder, H. White, N. X. Fang, M. J. Stoermer, G. Abbenante, J. L. Martin, P. R. Young, and D. P. Fairlie. 2001. Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J. Biol. Chem. 276:45762-45771.
-
(2001)
J. Biol. Chem
, vol.276
, pp. 45762-45771
-
-
Leung, D.1
Schroder, K.2
White, H.3
Fang, N.X.4
Stoermer, M.J.5
Abbenante, G.6
Martin, J.L.7
Young, P.R.8
Fairlie, D.P.9
-
15
-
-
37349023165
-
Crystal structure of the NS3 protease-helicase from dengue virus
-
Luo, D., T. Xu, C. Hunke, G. Gruber, S. G. Vasudevan, and J. Lescar. 2008. Crystal structure of the NS3 protease-helicase from dengue virus. J. Virol. 82:173-183.
-
(2008)
J. Virol
, vol.82
, pp. 173-183
-
-
Luo, D.1
Xu, T.2
Hunke, C.3
Gruber, G.4
Vasudevan, S.G.5
Lescar, J.6
-
16
-
-
0034963947
-
Mutagenesis of the dengue virus type 2 NS3 proteinase and the production of growth-restricted virus
-
Matusan, A. E., P. G. Kelley, M. J. Pryor, J. C. Whisstock, A. D. Davidson, and P. J. Wright. 2001. Mutagenesis of the dengue virus type 2 NS3 proteinase and the production of growth-restricted virus. J. Gen. Virol. 82:1647-1656.
-
(2001)
J. Gen. Virol
, vol.82
, pp. 1647-1656
-
-
Matusan, A.E.1
Kelley, P.G.2
Pryor, M.J.3
Whisstock, J.C.4
Davidson, A.D.5
Wright, P.J.6
-
17
-
-
55849093621
-
Phase I clinical evaluation of rDEN4Delta30-200,201: A live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity
-
McArthur, J. H., A. P. Durbin, J. A. Marron, K. A. Wanionek, B. Thumar, D. J. Pierro, A. C. Schmidt, J. E. Blaney, Jr., B. R. Murphy, and S. S. Whitehead. 2008. Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity. Am. J. Trop. Med. Hyg. 79:678-684.
-
(2008)
Am. J. Trop. Med. Hyg
, vol.79
, pp. 678-684
-
-
McArthur, J.H.1
Durbin, A.P.2
Marron, J.A.3
Wanionek, K.A.4
Thumar, B.5
Pierro, D.J.6
Schmidt, A.C.7
Blaney Jr., J.E.8
Murphy, B.R.9
Whitehead, S.S.10
-
18
-
-
23844546311
-
Likelihood-enhanced fast translation functions
-
McCoy, A. J., R. W. Grosse-Kunstleve, L. C. Storoni, and R. J. Read. 2005. Likelihood-enhanced fast translation functions. Acta Crystallogr. D Biol. Crystallogr. 61:458-464.
-
(2005)
Acta Crystallogr. D Biol. Crystallogr
, vol.61
, pp. 458-464
-
-
McCoy, A.J.1
Grosse-Kunstleve, R.W.2
Storoni, L.C.3
Read, R.J.4
-
20
-
-
43949136115
-
Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3
-
Neuman, B. W., J. S. Joseph, K. S. Saikatendu, P. Serrano, A. Chatterjee, M. A. Johnson, L. Liao, J. P. Klaus, J. R. Yates III, K. Wuthrich, R. C. Stevens, M. J. Buchmeier, and P. Kuhn. 2008. Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3. J. Virol. 82:5279-5294.
-
(2008)
J. Virol
, vol.82
, pp. 5279-5294
-
-
Neuman, B.W.1
Joseph, J.S.2
Saikatendu, K.S.3
Serrano, P.4
Chatterjee, A.5
Johnson, M.A.6
Liao, L.7
Klaus, J.P.8
Yates III, J.R.9
Wuthrich, K.10
Stevens, R.C.11
Buchmeier, M.J.12
Kuhn, P.13
-
21
-
-
52049104700
-
Docking of noncompetitive inhibitors into dengue virus type 2 protease: Understanding the interactions with allosteric binding sites
-
Othman, R., T. S. Kiat, N. Khalid, R. Yusof, E. I. Newhouse, J. S. Newhouse, M. Alam, and N. A. Rahman. 2008. Docking of noncompetitive inhibitors into dengue virus type 2 protease: understanding the interactions with allosteric binding sites. J. Chem. Infect. Model. 48:1582-1591.
-
(2008)
J. Chem. Infect. Model
, vol.48
, pp. 1582-1591
-
-
Othman, R.1
Kiat, T.S.2
Khalid, N.3
Yusof, R.4
Newhouse, E.I.5
Newhouse, J.S.6
Alam, M.7
Rahman, N.A.8
-
22
-
-
0031059866
-
Processing of X-ray diffraction data collected in oscillation mode
-
Otwinowski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
-
(1997)
Methods Enzymol
, vol.276
, pp. 307-326
-
-
Otwinowski, Z.1
Minor, W.2
-
23
-
-
65649118564
-
Attenuated D2 16681-PDK53 vaccine: Defining humoral and cell-mediated immunity
-
Rabablert, J., and S. Yoksan. 2009. Attenuated D2 16681-PDK53 vaccine: defining humoral and cell-mediated immunity. Curr. Pharm. Des. 15:1203-1211.
-
(2009)
Curr. Pharm. Des
, vol.15
, pp. 1203-1211
-
-
Rabablert, J.1
Yoksan, S.2
-
24
-
-
57149088067
-
Molecular targets for flavivirus drug discovery
-
Sampath, A., and R. Padmanabhan. 2009. Molecular targets for flavivirus drug discovery. Antiviral Res. 81:6-15.
-
(2009)
Antiviral Res
, vol.81
, pp. 6-15
-
-
Sampath, A.1
Padmanabhan, R.2
-
25
-
-
63349098458
-
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naive adults
-
Sun, W., D. Cunningham, S. S. Wasserman, J. Perry, J. R. Putnak, K. H. Eckels, D. W. Vaughn, S. J. Thomas, N. Kanesa-Thasan, B. L. Innis, and R. Edelman. 2009. Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naive adults. Hum. Vaccin. 5:33-40.
-
(2009)
Hum. Vaccin
, vol.5
, pp. 33-40
-
-
Sun, W.1
Cunningham, D.2
Wasserman, S.S.3
Perry, J.4
Putnak, J.R.5
Eckels, K.H.6
Vaughn, D.W.7
Thomas, S.J.8
Kanesa-Thasan, N.9
Innis, B.L.10
Edelman, R.11
-
26
-
-
64749108083
-
Structure-based discovery of dengue virus protease inhibitors
-
Tomlinson, S. M., R. D. Malmstrom, A. Russo, N. Mueller, Y. P. Pang, and S. J. Watowich. 2009. Structure-based discovery of dengue virus protease inhibitors. Antiviral Res. 82:110-114.
-
(2009)
Antiviral Res
, vol.82
, pp. 110-114
-
-
Tomlinson, S.M.1
Malmstrom, R.D.2
Russo, A.3
Mueller, N.4
Pang, Y.P.5
Watowich, S.J.6
-
27
-
-
27744520272
-
Peptide inhibitors of dengue virus NS3 protease. part 2: SAR study of tetrapeptide aldehyde inhibitors
-
Yin, Z., S. J. Patel, W. L. Wang, W. L. Chan, K. R. Ranga Rao, G. Wang, X. Ngew, V. Patel, D. Beer, J. E. Knox, N. L. Ma, C. Ehrhardt, S. P. Lim, S. G. Vasudevan, and T. H. Keller. 2006. Peptide inhibitors of dengue virus NS3 protease. part 2: SAR study of tetrapeptide aldehyde inhibitors. Bioorg. Med. Chem. Lett. 16:40-43.
-
(2006)
Bioorg. Med. Chem. Lett
, vol.16
, pp. 40-43
-
-
Yin, Z.1
Patel, S.J.2
Wang, W.L.3
Chan, W.L.4
Ranga Rao, K.R.5
Wang, G.6
Ngew, X.7
Patel, V.8
Beer, D.9
Knox, J.E.10
Ma, N.L.11
Ehrhardt, C.12
Lim, S.P.13
Vasudevan, S.G.14
Keller, T.H.15
-
28
-
-
27744581672
-
Peptide inhibitors of dengue virus NS3 protease. Part 1
-
Yin, Z., S. J. Patel, W. L. Wang, G. Wang, W. L. Chan, K. R. Rao, J. Alam, D. A. Jeyaraj, X. Ngew, V. Patel, D. Beer, S. P. Lim, S. G. Vasudevan, and T. H. Keller. 2006. Peptide inhibitors of dengue virus NS3 protease. Part 1: Warhead. Bioorg. Med. Chem. Lett. 16:36-39.
-
(2006)
Warhead. Bioorg. Med. Chem. Lett
, vol.16
, pp. 36-39
-
-
Yin, Z.1
Patel, S.J.2
Wang, W.L.3
Wang, G.4
Chan, W.L.5
Rao, K.R.6
Alam, J.7
Jeyaraj, D.A.8
Ngew, X.9
Patel, V.10
Beer, D.11
Lim, S.P.12
Vasudevan, S.G.13
Keller, T.H.14
-
29
-
-
0034616194
-
Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro
-
Yusof, R., S. Clum, M. Wetzel, H. M. Murthy, and R. Padmanabhan. 2000. Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J. Biol. Chem. 275:9963-9969.
-
(2000)
J. Biol. Chem
, vol.275
, pp. 9963-9969
-
-
Yusof, R.1
Clum, S.2
Wetzel, M.3
Murthy, H.M.4
Padmanabhan, R.5
|